chr5-177267592-C-T
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_Strong
The NM_022455.5(NSD1):c.5177C>T(p.Pro1726Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1726R) has been classified as Pathogenic.
Frequency
Consequence
NM_022455.5 missense
Scores
Clinical Significance
Conservation
Publications
- Beckwith-Wiedemann syndrome due to NSD1 mutationInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Sotos syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
- Sotos syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_022455.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NSD1 | NM_022455.5 | MANE Select | c.5177C>T | p.Pro1726Leu | missense | Exon 15 of 23 | NP_071900.2 | ||
| NSD1 | NM_001409301.1 | c.5177C>T | p.Pro1726Leu | missense | Exon 15 of 23 | NP_001396230.1 | |||
| NSD1 | NM_001409302.1 | c.5177C>T | p.Pro1726Leu | missense | Exon 15 of 23 | NP_001396231.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NSD1 | ENST00000439151.7 | TSL:1 MANE Select | c.5177C>T | p.Pro1726Leu | missense | Exon 15 of 23 | ENSP00000395929.2 | ||
| NSD1 | ENST00000347982.9 | TSL:1 | c.4304C>T | p.Pro1435Leu | missense | Exon 16 of 24 | ENSP00000343209.5 | ||
| NSD1 | ENST00000503056.6 | TSL:5 | c.-182C>T | 5_prime_UTR_premature_start_codon_gain | Exon 2 of 10 | ENSP00000424024.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Sotos syndrome Pathogenic:1
The variant is not observed in the gnomAD v4.1.0 dataset. Predicted Consequence/Location: The variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported (PMID: 12464997). In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.89 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.99 (>=0.6, sensitivity 0.72 and precision 0.9)]. The same nucleotide change resulting in the same amino acid change has been previously reported to be associated with NSD1-related disorder (PMID: 14517949).A different missense change at the same codon (p.Pro1726Arg) has been reported to be associated with NSD1-related disorder (ClinVar ID: VCV000454055 /PMID: 26690673). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at